These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 24717798)

  • 1. Receptor mimicry by antibody F045-092 facilitates universal binding to the H3 subtype of influenza virus.
    Lee PS; Ohshima N; Stanfield RL; Yu W; Iba Y; Okuno Y; Kurosawa Y; Wilson IA
    Nat Commun; 2014 Apr; 5():3614. PubMed ID: 24717798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
    Qiu Y; Stegalkina S; Zhang J; Boudanova E; Park A; Zhou Y; Prabakaran P; Pougatcheva S; Ustyugova IV; Vogel TU; Mundle ST; Oomen R; Delagrave S; Ross TM; Kleanthous H; Qiu H
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31826999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity.
    Lee PS; Yoshida R; Ekiert DC; Sakai N; Suzuki Y; Takada A; Wilson IA
    Proc Natl Acad Sci U S A; 2012 Oct; 109(42):17040-5. PubMed ID: 23027945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conserved neutralizing epitope at globular head of hemagglutinin in H3N2 influenza viruses.
    Iba Y; Fujii Y; Ohshima N; Sumida T; Kubota-Koketsu R; Ikeda M; Wakiyama M; Shirouzu M; Okada J; Okuno Y; Kurosawa Y; Yokoyama S
    J Virol; 2014 Jul; 88(13):7130-44. PubMed ID: 24719430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A broadly neutralizing human monoclonal antibody directed against a novel conserved epitope on the influenza virus H3 hemagglutinin globular head.
    Benjamin E; Wang W; McAuliffe JM; Palmer-Hill FJ; Kallewaard NL; Chen Z; Suzich JA; Blair WS; Jin H; Zhu Q
    J Virol; 2014 Jun; 88(12):6743-50. PubMed ID: 24696468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naturally occurring antibodies in humans can neutralize a variety of influenza virus strains, including H3, H1, H2, and H5.
    Ohshima N; Iba Y; Kubota-Koketsu R; Asano Y; Okuno Y; Kurosawa Y
    J Virol; 2011 Nov; 85(21):11048-57. PubMed ID: 21865387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
    Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A small-molecule fragment that emulates binding of receptor and broadly neutralizing antibodies to influenza A hemagglutinin.
    Kadam RU; Wilson IA
    Proc Natl Acad Sci U S A; 2018 Apr; 115(16):4240-4245. PubMed ID: 29610325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza Virus Hemagglutinins H2, H5, H6, and H11 Are Not Targets of Pulmonary Surfactant Protein D:
    Parsons LM; An Y; Qi L; White MR; van der Woude R; Hartshorn KL; Taubenberger JK; de Vries RP; Cipollo JF
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31826991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.
    Zost SJ; Parkhouse K; Gumina ME; Kim K; Diaz Perez S; Wilson PC; Treanor JJ; Sant AJ; Cobey S; Hensley SE
    Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12578-12583. PubMed ID: 29109276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.
    Yoshida R; Igarashi M; Ozaki H; Kishida N; Tomabechi D; Kida H; Ito K; Takada A
    PLoS Pathog; 2009 Mar; 5(3):e1000350. PubMed ID: 19300497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody recognition of the pandemic H1N1 Influenza virus hemagglutinin receptor binding site.
    Hong M; Lee PS; Hoffman RM; Zhu X; Krause JC; Laursen NS; Yoon SI; Song L; Tussey L; Crowe JE; Ward AB; Wilson IA
    J Virol; 2013 Nov; 87(22):12471-80. PubMed ID: 24027321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of N-glycosylation sites on the globular head of the H5 hemagglutinin induces the escape of highly pathogenic avian influenza A H5N1 viruses from vaccine-induced immunity.
    Hervé PL; Lorin V; Jouvion G; Da Costa B; Escriou N
    Virology; 2015 Dec; 486():134-45. PubMed ID: 26433051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins.
    Wang TT; Tan GS; Hai R; Pica N; Petersen E; Moran TM; Palese P
    PLoS Pathog; 2010 Feb; 6(2):e1000796. PubMed ID: 20195520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conserved stem fragment from H3 influenza hemagglutinin elicits cross-clade neutralizing antibodies through stalk-targeted blocking of conformational change during membrane fusion.
    Gong X; Yin H; Shi Y; Guan S; He X; Yang L; Yu Y; Kuai Z; Jiang C; Kong W; Wang S; Shan Y
    Immunol Lett; 2016 Apr; 172():11-20. PubMed ID: 26875772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Insights into Reovirus σ1 Interactions with Two Neutralizing Antibodies.
    Dietrich MH; Ogden KM; Katen SP; Reiss K; Sutherland DM; Carnahan RH; Goff M; Cooper T; Dermody TS; Stehle T
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An IgM antibody targeting the receptor binding site of influenza B blocks viral infection with great breadth and potency.
    Shen C; Zhang M; Chen Y; Zhang L; Wang G; Chen J; Chen S; Li Z; Wei F; Chen J; Yang K; Guo S; Wang Y; Zheng Q; Yu H; Luo W; Zhang J; Chen H; Chen Y; Xia N
    Theranostics; 2019; 9(1):210-231. PubMed ID: 30662563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-neutralization of influenza A viruses mediated by a single antibody loop.
    Ekiert DC; Kashyap AK; Steel J; Rubrum A; Bhabha G; Khayat R; Lee JH; Dillon MA; O'Neil RE; Faynboym AM; Horowitz M; Horowitz L; Ward AB; Palese P; Webby R; Lerner RA; Bhatt RR; Wilson IA
    Nature; 2012 Sep; 489(7417):526-32. PubMed ID: 22982990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A highly conserved neutralizing epitope on group 2 influenza A viruses.
    Ekiert DC; Friesen RH; Bhabha G; Kwaks T; Jongeneelen M; Yu W; Ophorst C; Cox F; Korse HJ; Brandenburg B; Vogels R; Brakenhoff JP; Kompier R; Koldijk MH; Cornelissen LA; Poon LL; Peiris M; Koudstaal W; Wilson IA; Goudsmit J
    Science; 2011 Aug; 333(6044):843-50. PubMed ID: 21737702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Antibodies Targeting the H3N2 Hemagglutinin Receptor Binding Site following Vaccination of Humans.
    Zost SJ; Lee J; Gumina ME; Parkhouse K; Henry C; Wu NC; Lee CD; Wilson IA; Wilson PC; Bloom JD; Hensley SE
    Cell Rep; 2019 Dec; 29(13):4460-4470.e8. PubMed ID: 31875553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.